Search
Phosphatidylethanolamine Biosynthesis PE(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
smpdb.ca/view/SMP0127201MetabolicPhosphatidylethanolamines (PE) are a class of phospholipids that incorporate a phosphoric acid headgroup into a diacylglycerol backbone. They are the second most abundant phospholipid in eukaryotic cell membranes, and contrary to phospha...
Phosphatidylethanolamine Biosynthesis PE(18:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
smpdb.ca/view/SMP0127256MetabolicPhosphatidylethanolamines (PE) are a class of phospholipids that incorporate a phosphoric acid headgroup into a diacylglycerol backbone. They are the second most abundant phospholipid in eukaryotic cell membranes, and contrary to phospha...
Phosphatidylethanolamine Biosynthesis PE(22:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
smpdb.ca/view/SMP0127558MetabolicPhosphatidylethanolamines (PE) are a class of phospholipids that incorporate a phosphoric acid headgroup into a diacylglycerol backbone. They are the second most abundant phospholipid in eukaryotic cell membranes, and contrary to phospha...
Phosphatidylethanolamine Biosynthesis PE(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/20:0)
smpdb.ca/view/SMP0127584MetabolicPhosphatidylethanolamines (PE) are a class of phospholipids that incorporate a phosphoric acid headgroup into a diacylglycerol backbone. They are the second most abundant phospholipid in eukaryotic cell membranes, and contrary to phospha...
SI-109
go.drugbank.com/drugs/DB32603ExperimentalSI-109 is a potent, small-molecule inhibitor of the STAT3 SH2 domain.[A275443]
Cardiolipin Biosynthesis CL(20:2(11Z,14Z)/20:2(11Z,14Z)/20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
smpdb.ca/view/SMP0246716MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:2(11Z,14Z)/20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z))
smpdb.ca/view/SMP0246766MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Avacopan
go.drugbank.com/drugs/DB15011ApprovedInvestigational[L39850] Avacopan was approved by Health Canada on April 20, 2022.[L41650] … AAV may be associated with necrotizing and crescentic glomerulonephritis (NCGN).
Cardiolipin Biosynthesis CL(20:2(11Z,14Z)/20:2(11Z,14Z)/20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
smpdb.ca/view/SMP0246717MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(20:2(11Z,14Z)/20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
smpdb.ca/view/SMP0246780MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.